Nasdaq Welcomes Calyxt (Nasdaq: CLXT) to The Nasdaq Stock Market
21 July 2017 - 1:23AM
Calyxt (Nasdaq:CLXT), a consumer-centric, food- and
agriculture-focused company, visited the Nasdaq MarketSite in Times
Square today in celebration of its initial public offering (IPO) on
The Nasdaq Stock Market.
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/4d4663f1-9ea8-49ec-8f8e-fe7b0f8308e6
http://www.globenewswire.com/NewsRoom/AttachmentNg/43493e68-16d9-4217-9db0-b60825368e65
Calyxt seeks to bridge the divide between evolving consumer
preferences and the historical approach by the large legacy
companies in the agriculture supply chain. By combining its leading
gene editing technology and technical expertise with its innovative
commercial strategy, Calyxt is pioneering a paradigm shift to
deliver healthier specialty food ingredients for consumers and
agriculturally advantageous crop traits to farmers.
“As more and more food companies are looking for specialty
ingredients that can help them to satisfy customers’ evolving needs
and desire to lead healthier lifestyles, Calyxt is perfectly
positioned to be an industry leader with the emergence of gene
editing as a truly game-changing technology in the food space,”
said Federico Tripodi, CEO, Calyxt. “Coupled with our innovative
commercial strategy, this will allow Calyxt to meet the needs of
today’s consumer preferences – all of the while helping to shape
the landscape for the future of food as we know it.”
“Calyxt believes that the precision, specificity,
cost-effectiveness and development speed of the company’s gene
editing technologies will enable it to provide meaningful
disruption to the food and agriculture industries. We are proud to
welcome Calyxt to the Nasdaq family of innovators,” said Nelson
Griggs, Executive Vice President, Head of Global Listings,
Nasdaq.
The information contained above is provided for informational
and educational purposes only, and nothing contained herein should
be construed as investment advice, either on behalf of a particular
security or an overall investment strategy. Information about the
company is provided by the company or comes from the company’s
public filings and is not independently verified by Nasdaq.
Neither Nasdaq nor any of its affiliates makes any recommendation
to buy or sell any security or any representation about the
financial condition of any company. Statements regarding
Nasdaq-listed companies are not guarantees of future performance.
Actual results may differ materially from those expressed or
implied. Past performance is not indicative of future results.
Investors should undertake their own due diligence and carefully
evaluate companies before investing. ADVICE FROM A SECURITIES
PROFESSIONAL IS STRONGLY ADVISED.
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 90
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to 3,800 total listings with a market
value of $11 trillion. To learn more, visit:
http://business.nasdaq.com
About CalyxtCalyxt, Inc. is a consumer-centric,
food- and agriculture-focused company. By combining its leading
gene-editing technology and technical expertise with its innovative
commercial strategy, Calyxt is pioneering a paradigm shift to
deliver healthier food ingredients, such as healthier oils and high
fiber wheat, for consumers and agriculturally advantageous crop
traits, such as herbicide tolerance, for farmers. Calyxt is located
in Minneapolis-St. Paul, Minn., and is a wholly owned subsidiary of
Cellectis.
For further information please visit our website:
www.calyxt.comCalyxt™ and the corporate logo are trademarks owned
by Calyxt, Inc.Talking about gene editing? We do it.
TALEN® is a registered trademark owned by the Cellectis
Group.
- NDAQG -
Media Relations Contacts:
Stephanie Lowenthal
(646) 441-5073
Stephanie.Lowenthal@nasdaq.com
Emily Pan
(646) 441-5120
emily.pan@nasdaq.com
Caitlin Kasunich / Nick Opich
KCSA Strategic Communications
212.896.1241 / 212.896.1206
ckasunich@kcsa.com / nopich@kcsa.com
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From Apr 2024 to May 2024
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From May 2023 to May 2024